Thrombocytopenia Therapy
Study data from Albany College of Pharmacy, College of Pharmacy update understanding of thrombocytopenia therapy
Published in Blood Weekly, May 10th, 2007
Investigators publish new data in the report "Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia." According to recent research from the United States, "Heparin-induced thrombocytopenia (HIT) is a serious, immune-related complication of heparin therapy. One of the most severe manifestations of HIT is the development of thromboembolic events, which is based on platelet activation and aggregation caused by HIT-associated antibodies."
"Therapeutic options for patients with HIT are limited despite advancement toward the development of alternative (nonheparin) anticoagulants, such as direct thrombin inhibitors and indirect anti-factor Xa agents....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2007-05-10)
More Articles from Blood Weekly
- Gene Therapy
New treatment for fungus which causes thrush and sepsis - Anemia
Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease - Anemia
Aranesp "145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer - Anemia
Prospective Model Outlined Potential Time and Cost Savings of Once-Monthly Anemia Treatment - Cancer
Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential to Accelerate Recovery of Bone Marrow Stem Cells Following Cancer Radiation Therapy - Leukemia
Gemin X Presents Positive Preclinical Data of GX15-070 in Infant ALL at AACR Meeting -Targeted Cancer Therapy Demonstrates Potent Single Agent Activity and Synergy with Other Drugs- - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
